Table1. Impact of PET-CT on patient staging and management in non-small cell lung carcinoma (NSCLC).
| Study | N of patients | Change of stage (%) | Impact on management (%) |
|---|---|---|---|
| Lewis et al. (47) | 34 | – | 41 |
| Bury et al. (48) | 109 | 34 | 25 |
| Saunders et al. (49) | 97 | 27 | 37 |
| Pieterman et al. (50) | 102 | 62 | – |
| Hicks et al. (51) | 153 | 43 | 35 |
| Hoekstra et al. (52) | 57 | 30 | 19 |
| Schmucking et al. (53) | 63 | – | 52 |
| Zhou et al. (30) | 54 | 25.9 | – |
| Takeuchi et al. (54) | 592 | 28.7 | 37.2 |
| Taus et al. (55) | 246 | 35 | – |
| Zheng et al. (56) | 23 | 35 | – |
| Kirmani et al. (32) | 312 | 25.3 | – |
PET-CT, positron emission tomography-computed tomography.